JP2021513533A5 - - Google Patents
Info
- Publication number
- JP2021513533A5 JP2021513533A5 JP2020542733A JP2020542733A JP2021513533A5 JP 2021513533 A5 JP2021513533 A5 JP 2021513533A5 JP 2020542733 A JP2020542733 A JP 2020542733A JP 2020542733 A JP2020542733 A JP 2020542733A JP 2021513533 A5 JP2021513533 A5 JP 2021513533A5
- Authority
- JP
- Japan
- Prior art keywords
- γpantifol
- gamma
- composition according
- polyglutamine
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024075778A JP7676063B2 (ja) | 2018-02-07 | 2024-05-08 | ガンマポリグルタミン酸化葉酸代謝拮抗薬およびその使用 |
| JP2025070872A JP7884876B2 (ja) | 2018-02-07 | 2025-04-22 | ガンマポリグルタミン酸化葉酸代謝拮抗薬およびその使用 |
Applications Claiming Priority (29)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862627732P | 2018-02-07 | 2018-02-07 | |
| US201862627733P | 2018-02-07 | 2018-02-07 | |
| US62/627,733 | 2018-02-07 | ||
| US62/627,732 | 2018-02-07 | ||
| US201862630620P | 2018-02-14 | 2018-02-14 | |
| US201862630751P | 2018-02-14 | 2018-02-14 | |
| US201862630824P | 2018-02-14 | 2018-02-14 | |
| US201862630625P | 2018-02-14 | 2018-02-14 | |
| US201862630613P | 2018-02-14 | 2018-02-14 | |
| US201862630652P | 2018-02-14 | 2018-02-14 | |
| US62/630,613 | 2018-02-14 | ||
| US62/630,625 | 2018-02-14 | ||
| US62/630,751 | 2018-02-14 | ||
| US62/630,652 | 2018-02-14 | ||
| US62/630,620 | 2018-02-14 | ||
| US62/630,824 | 2018-02-14 | ||
| US201862636289P | 2018-02-28 | 2018-02-28 | |
| US62/636,289 | 2018-02-28 | ||
| US201862662372P | 2018-04-25 | 2018-04-25 | |
| US62/662,372 | 2018-04-25 | ||
| US201862702774P | 2018-07-24 | 2018-07-24 | |
| US201862702779P | 2018-07-24 | 2018-07-24 | |
| US62/702,774 | 2018-07-24 | ||
| US62/702,779 | 2018-07-24 | ||
| US201862764951P | 2018-08-17 | 2018-08-17 | |
| US201862764945P | 2018-08-17 | 2018-08-17 | |
| US62/764,945 | 2018-08-17 | ||
| US62/764,951 | 2018-08-17 | ||
| PCT/US2019/017004 WO2019157148A1 (en) | 2018-02-07 | 2019-02-07 | Gamma polyglutamated antifolates and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024075778A Division JP7676063B2 (ja) | 2018-02-07 | 2024-05-08 | ガンマポリグルタミン酸化葉酸代謝拮抗薬およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021513533A JP2021513533A (ja) | 2021-05-27 |
| JP2021513533A5 true JP2021513533A5 (cg-RX-API-DMAC10.html) | 2022-02-16 |
| JP7490240B2 JP7490240B2 (ja) | 2024-05-27 |
Family
ID=67548055
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542733A Active JP7490240B2 (ja) | 2018-02-07 | 2019-02-07 | ガンマポリグルタミン酸化葉酸代謝拮抗薬およびその使用 |
| JP2024075778A Active JP7676063B2 (ja) | 2018-02-07 | 2024-05-08 | ガンマポリグルタミン酸化葉酸代謝拮抗薬およびその使用 |
| JP2025070872A Active JP7884876B2 (ja) | 2018-02-07 | 2025-04-22 | ガンマポリグルタミン酸化葉酸代謝拮抗薬およびその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024075778A Active JP7676063B2 (ja) | 2018-02-07 | 2024-05-08 | ガンマポリグルタミン酸化葉酸代謝拮抗薬およびその使用 |
| JP2025070872A Active JP7884876B2 (ja) | 2018-02-07 | 2025-04-22 | ガンマポリグルタミン酸化葉酸代謝拮抗薬およびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3749321A4 (cg-RX-API-DMAC10.html) |
| JP (3) | JP7490240B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN111936147A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3090505A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2019157148A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180236098A1 (en) | 2016-08-12 | 2018-08-23 | L.E.A.F. Holdings Group Llc | Alpha and gamma-d polyglutamated antifolates and uses thereof |
| KR102584446B1 (ko) | 2016-08-12 | 2023-10-04 | 엘.이.에이.에프. 홀딩스 그룹 엘엘씨. | 알파 및 감마-d 폴리글루타메이트화 항엽산 및 이의 용도 |
| CA3090391A1 (en) | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated raltitrexed and uses thereof |
| US12246019B2 (en) | 2018-02-07 | 2025-03-11 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated lometrexol and uses thereof |
| JP7491573B2 (ja) | 2018-02-07 | 2024-05-28 | エル.イー.エー.エフ. ホールディングス グループ エルエルシー | アルファポリグルタミン酸化メトトレキセートおよびその使用 |
| US12220431B2 (en) | 2018-02-07 | 2025-02-11 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated antifolates and uses thereof |
| WO2019157146A1 (en) | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated antifolates and uses thereof |
| JP7514533B2 (ja) | 2018-02-07 | 2024-07-11 | エル.イー.エー.エフ. ホールディングス グループ エルエルシー | アルファポリグルタミン酸化テトラヒドロ葉酸およびその使用 |
| EP3749317A4 (en) | 2018-02-07 | 2022-06-22 | L.E.A.F Holdings Group LLC | PEMETREXED ALPHA-POLYGLUTAMATE AND ASSOCIATED USES |
| WO2019157129A1 (en) | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated pralatrexate and uses thereof |
| US12246018B2 (en) | 2018-02-07 | 2025-03-11 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated pemetrexed and uses thereof |
| WO2019157133A1 (en) | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated raltitrexed and uses thereof |
| CA3090384A1 (en) | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated aminopterin and uses thereof |
| CA3090943A1 (en) * | 2018-02-14 | 2019-08-22 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated aminopterin and uses thereof |
| US12048767B2 (en) | 2018-02-14 | 2024-07-30 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated pralatrexate and uses thereof |
| CA3090875A1 (en) | 2018-02-14 | 2019-08-22 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated lometrexol and uses thereof |
| US12290518B2 (en) | 2018-02-14 | 2025-05-06 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated methotrexate and uses thereof |
| JP7442822B2 (ja) * | 2018-02-14 | 2024-03-05 | エル.イー.エー.エフ. ホールディングス グループ エルエルシー | γポリグルタミン酸化テトラヒドロ葉酸およびその使用 |
| CA3149914A1 (en) * | 2019-08-06 | 2021-02-11 | L.E.A.F. Holdings Group Llc | Processes of preparing polyglutamated antifolates and uses of their compositions |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6569432B1 (en) * | 1995-02-24 | 2003-05-27 | Sloan-Kettering Institute For Cancer Research | Prostate-specific membrane antigen and uses thereof |
| US20020168761A1 (en) * | 2000-01-24 | 2002-11-14 | Gour Barbara J. | Peptidomimetic modulators of cell adhesion |
| US7612071B2 (en) * | 2004-03-12 | 2009-11-03 | Syntrix Biosystems, Inc. | Compositions and methods employing aminopterin |
| JP2008512490A (ja) * | 2004-09-08 | 2008-04-24 | チェルシー・セラピューティクス,インコーポレイテッド | 異常細胞増殖および炎症の障害を治療するための代謝的に不活性な葉酸拮抗剤 |
| US7687473B2 (en) * | 2005-01-07 | 2010-03-30 | Health Research, Inc. | 5-amino-4-imidazolecarboxamide riboside and its nucleobase as potentiators of antifolate transport and metabolism |
| US8073630B2 (en) * | 2006-08-30 | 2011-12-06 | Exagen Diagnostics, Inc. | Pharacogenetic method for prediction of the efficacy of methotrexate monotherapy in recent-onset arthritis |
| CA2674075C (en) * | 2006-12-29 | 2012-10-30 | Charles P. Theuer | Antifolate agent combinations in the treatment of cancer |
| AU2008206161A1 (en) * | 2007-01-19 | 2008-07-24 | Chelsea Therapeutics, Inc. | New classical antifolates |
| EP2437596B1 (en) * | 2009-06-03 | 2017-05-03 | Ex-Tek, LLC | Skin treatment compositions |
| US9770414B2 (en) * | 2010-05-13 | 2017-09-26 | Pacira Pharmaceuticals, Inc. | Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent |
| PL226015B1 (pl) | 2011-03-03 | 2017-06-30 | Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną | Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna |
| CN103040748B (zh) * | 2012-12-18 | 2014-07-02 | 海南圣欣医药科技有限公司 | 一种培美曲塞二钠脂质体注射剂 |
| US20160228573A1 (en) * | 2014-08-14 | 2016-08-11 | L.E.A.F. Holdings Group Llc | Liposome encapsulated affinity drug |
| KR102584446B1 (ko) * | 2016-08-12 | 2023-10-04 | 엘.이.에이.에프. 홀딩스 그룹 엘엘씨. | 알파 및 감마-d 폴리글루타메이트화 항엽산 및 이의 용도 |
| US20180236098A1 (en) * | 2016-08-12 | 2018-08-23 | L.E.A.F. Holdings Group Llc | Alpha and gamma-d polyglutamated antifolates and uses thereof |
| WO2018031979A1 (en) * | 2016-08-12 | 2018-02-15 | L.E.A.F. Holdings Group Llc | Alpha and gamma-d polyglutamated antifolates and uses thereof |
| EP3706801B1 (en) * | 2017-11-08 | 2026-01-14 | L.E.A.F Holdings Group LLC | Platinum complexes and uses thereof |
| WO2019157129A1 (en) * | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated pralatrexate and uses thereof |
| CA3090391A1 (en) * | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated raltitrexed and uses thereof |
| US12246019B2 (en) * | 2018-02-07 | 2025-03-11 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated lometrexol and uses thereof |
| EP3749317A4 (en) * | 2018-02-07 | 2022-06-22 | L.E.A.F Holdings Group LLC | PEMETREXED ALPHA-POLYGLUTAMATE AND ASSOCIATED USES |
| CA3090384A1 (en) * | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated aminopterin and uses thereof |
| WO2019157133A1 (en) * | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated raltitrexed and uses thereof |
| JP7491573B2 (ja) * | 2018-02-07 | 2024-05-28 | エル.イー.エー.エフ. ホールディングス グループ エルエルシー | アルファポリグルタミン酸化メトトレキセートおよびその使用 |
| US12246018B2 (en) * | 2018-02-07 | 2025-03-11 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated pemetrexed and uses thereof |
| JP7514533B2 (ja) * | 2018-02-07 | 2024-07-11 | エル.イー.エー.エフ. ホールディングス グループ エルエルシー | アルファポリグルタミン酸化テトラヒドロ葉酸およびその使用 |
| WO2019157146A1 (en) * | 2018-02-07 | 2019-08-15 | L.E.A.F. Holdings Group Llc | Alpha polyglutamated antifolates and uses thereof |
| JP7442822B2 (ja) * | 2018-02-14 | 2024-03-05 | エル.イー.エー.エフ. ホールディングス グループ エルエルシー | γポリグルタミン酸化テトラヒドロ葉酸およびその使用 |
| US12290518B2 (en) * | 2018-02-14 | 2025-05-06 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated methotrexate and uses thereof |
| US12048767B2 (en) * | 2018-02-14 | 2024-07-30 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated pralatrexate and uses thereof |
| CA3090943A1 (en) * | 2018-02-14 | 2019-08-22 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated aminopterin and uses thereof |
| CA3090875A1 (en) * | 2018-02-14 | 2019-08-22 | L.E.A.F. Holdings Group Llc | Gamma polyglutamated lometrexol and uses thereof |
-
2019
- 2019-02-07 WO PCT/US2019/017004 patent/WO2019157148A1/en not_active Ceased
- 2019-02-07 CN CN201980024669.5A patent/CN111936147A/zh active Pending
- 2019-02-07 CA CA3090505A patent/CA3090505A1/en active Pending
- 2019-02-07 JP JP2020542733A patent/JP7490240B2/ja active Active
- 2019-02-07 EP EP19752055.4A patent/EP3749321A4/en active Pending
-
2024
- 2024-05-08 JP JP2024075778A patent/JP7676063B2/ja active Active
-
2025
- 2025-04-22 JP JP2025070872A patent/JP7884876B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021513529A5 (cg-RX-API-DMAC10.html) | ||
| JP2021513550A5 (cg-RX-API-DMAC10.html) | ||
| JP2021513528A5 (cg-RX-API-DMAC10.html) | ||
| JP2021513531A5 (cg-RX-API-DMAC10.html) | ||
| JP2021513525A5 (cg-RX-API-DMAC10.html) | ||
| JP2021512895A5 (cg-RX-API-DMAC10.html) | ||
| JP2021514357A5 (cg-RX-API-DMAC10.html) | ||
| JP2017526744A5 (cg-RX-API-DMAC10.html) | ||
| JP2019524885A5 (cg-RX-API-DMAC10.html) | ||
| JP2025072362A5 (cg-RX-API-DMAC10.html) | ||
| JP2019524802A5 (cg-RX-API-DMAC10.html) | ||
| Nowak et al. | Size, shape, and flexibility influence nanoparticle transport across brain endothelium under flow | |
| Jain et al. | Comparison of avidin, neutravidin, and streptavidin as nanocarriers for efficient siRNA delivery | |
| Schulz et al. | Beyond the lipid-bilayer: interaction of polymers and nanoparticles with membranes | |
| Xu et al. | Impact of surface polyethylene glycol (PEG) density on biodegradable nanoparticle transport in mucus ex vivo and distribution in vivo | |
| Suk et al. | Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier | |
| Liu et al. | Formulation of drugs in block copolymer micelles: drug loading and release | |
| AU2011323458B2 (en) | Compositions and methods for the delivery of therapeutics | |
| JP6538031B2 (ja) | 薬物を負荷した二重特異性リガンド標的化ミニ細胞およびインターフェロン−γを用いた併用腫瘍治療 | |
| US20160303047A1 (en) | Means for lung specific delivery | |
| García et al. | pH-temperature dual-sensitive nucleolipid-containing stealth liposomes anchored with PEGylated AuNPs for triggering delivery of doxorubicin | |
| CN111954530A (zh) | γ聚谷氨酸化培美曲塞及其用途 | |
| Kiss et al. | Tuneable surface modification of PLGA nanoparticles carrying new antitubercular drug candidate | |
| US20220096382A1 (en) | Polymersomes functionalised with multiple ligands | |
| AU2020349613B2 (en) | Immune stimulating micelle composition |